SCHW
64
2
ZBH
60
-2
DVN
16
3
VRTX
46
2
WDC
41
-2
WMT
74
2
ROK
55
8
F
43
-8
EW
37
-2
TXT
48
2
AMGN
44
5
PBI
60
-5
GM
65
-3
HOG
29
-4
HCP
58
4
DHI
48
3
ORLY
53
-3
V
60
-6
IFF
53
2
HRB
51
2
SCHW
64
2
ZBH
60
-2
DVN
16
3
VRTX
46
2
WDC
41
-2
WMT
74
2
ROK
55
8
F
43
-8
EW
37
-2
TXT
48
2
AMGN
44
5
PBI
60
-5
GM
65
-3
HOG
29
-4
HCP
58
4
DHI
48
3
ORLY
53
-3
V
60
-6
IFF
53
2
HRB
51
2
Financhill
Back

Amicus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
25

FOLD
Amicus Therapeutics

Last Price:
9.49
Seasonality Move:
7.75%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
246.88
Seasonality Move:
10.85%
Sell
25
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.59. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $246.80. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $246.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.39 Sell
Relative Strength Index (14 RSI): 29.32 Sell
Chaikin Money Flow: 783674 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.62 Sell
Relative Strength Index (14 RSI): 38.74 Sell
Chaikin Money Flow: -304936 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (252.02 - 290.24) Sell
Bollinger Bands (100): (248.77 - 281.71) Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.01 Sell
20-day SMA: 10.86 Sell
50-day SMA: 10.88 Sell
200-day SMA: 11.01 Sell
8-day EMA: 10 Sell
20-day EMA: 10.52 Sell
50-day EMA: 10.8 Sell
200-day EMA: 11.03 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 248.63 Sell
20-day SMA: 265.26 Sell
50-day SMA: 272.83 Sell
200-day SMA: 211.25 Buy
8-day EMA: 249.36 Sell
20-day EMA: 260.88 Sell
50-day EMA: 266.13 Sell
200-day EMA: 230.89 Buy

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):